Dr Fin Slevin
- Position: Associate Professor and Honorary Consultant in Clinical Oncology
- Areas of expertise: clinical oncology; radiotherapy; uro-oncology; clinical trials; reirradiation
- Email: F.M.Slevin@leeds.ac.uk
Profile
I am an Associate Professor at University of Leeds and Honorary Consultant in Clinical Oncology at Leeds Teaching Hospitals NHS Trust. I commenced an NIHR Advanced Fellowship in April 2025 focused on optimising radiotherapy for prostate cancer. My clinical practice primarily concerns the treatment of urological cancers. I undertook a Cancer Research UK Clinical Trials Fellowship focused on radiotherapy clinical trials between April 2022 and March 2025. I completed a BSc with Honours of the First Class in Medicine at University of St Andrews in 2007 and MBChB with Honours and Distinction at University of Manchester in 2010. I completed a PhD in technical radiotherapy research, focused on Stereotactic Ablative Radiotherapy in the pelvis, within the Cancer Research UK Advanced Radiotherapy Network (ART-NET) programme at University of Leeds in March 2022. I completed my Clinical Oncology training at Leeds Teaching Hospitals NHS Trust and was awarded my Certificate of Completion of Training (CCT) in May 2022. I was appointed as an Honorary Consultant in Clinical Oncology at University of Leeds and Leeds Teaching Hospitals NHS Trust in November 2022.
Research interests
My current research in the NIHR Advanced Fellowship is focused on optimising radiotherapy for prostate cancer, utilising existing radiotherapy clinical trial datasets and patient perspectives in the MAPP-RT (Modelling And Patient Perspective to optimise pelvic Radiotherapy) study to understand why patients get radiotherapy side effects, the impact for patients and how radiotherapy design can be optimised to reduce these risks. During my Cancer Research UK Clinical Trials Fellowship, I worked with the Cancer Research UK Leeds Clinical Trials Unit on the design, set-up and conduct of radiotherapy clinical trials. I am Co-Chief Investigator of the Yorkshire Cancer Research-funded Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) UK multicentre phase 3 randomised controlled trial. I am interested in novel radiotherapy techniques, including Stereotactic Ablative Radiotherapy, proton beam therapy and the delivery of a second course of radiotherapy close to a previously treated area (known as reirradiation).
Qualifications
- BSc (Hons)
- MBChB
- MRCP
- FRCR
- PhD
Student education
I am a Fellow of the Higher Education Academy (FHEA), awarded under the University of Leeds Professional Recognition in Student Education (PRiSE) scheme in August 2020. I am Co-Lead for the Cancer and Continuing Care module for 4th year medical students at University of Leeds.
Research groups and institutes
- Leeds Institute of Medical Research at St James's
- The Radiotherapy Research Group